ezetimibe has been researched along with Ischemic Stroke in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amarenco, P; Bruckert, E; Charles, H; Giroud, M; Kim, JS; Labreuche, J; Lavallée, PC; Lee, BC; Mahagne, MH; Meseguer, E; Nighoghossian, N; Steg, PG; Vicaut, É | 2 |
| Hackam, DG; Hegele, RA | 1 |
| Hu, WS; Lin, CL; Yu, TS | 1 |
| Aker, A; Naoum, I; Saliba, W; Zafrir, B | 1 |
| Amarenco, P; Bruckert, E; Charles, H; Gabriel Steg, P; Giroud, M; Hobeanu, C; Labreuche, J; Lavallée, PC; Meseguer, E; Touboul, PJ; Vicaut, É | 1 |
1 review(s) available for ezetimibe and Ischemic Stroke
| Article | Year |
|---|---|
Lipid-Modifying Therapies and Stroke Prevention.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Ezetimibe; Hemorrhagic Stroke; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Lipids; Proprotein Convertase 9; Stroke | 2022 |
2 trial(s) available for ezetimibe and Ischemic Stroke
| Article | Year |
|---|---|
Intracranial Hemorrhage in the TST Trial.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Coronary Artery Disease; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Intracranial Arteriosclerosis; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Secondary Prevention; Young Adult | 2022 |
Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Cholesterol, LDL; Ezetimibe; Female; Follow-Up Studies; Humans; Ischemic Stroke; Male; Middle Aged; Ultrasonography | 2020 |
3 other study(ies) available for ezetimibe and Ischemic Stroke
| Article | Year |
|---|---|
Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke.
Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Diabetes Mellitus, Type 2; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Simvastatin; Stroke; Treatment Outcome | 2023 |
Guideline-Directed Low-Density Lipoprotein Cholesterol Management After Acute Ischemic Stroke: Findings from a National Health Care Service.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Delivery of Health Care; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Stroke; Stroke | 2023 |
Impact of Lower Versus Higher LDL Cholesterol Targets on Cardiovascular Events After Ischemic Stroke in Patients With Diabetes.
Topics: Aged; Cholesterol, LDL; Diabetes Mellitus, Type 2; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Stroke; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2021 |